Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
9Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
Kestra Medical Technologies, Ltd. (KMTS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
17Total relationships
1Distinct source URLs
4High confidence
0.699Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Kestra Medical Technologies, Ltd. Suppliers
Ticker
Name
Confidence
Evidence
WEST-AFFUM-LP
WEST-AFFUM-LP
80%
In March 2025, the Company raised $ 215,789 in proceeds in the IPO after deducting underwriting discounts and commissions and before deducting IPO offering costs of
BOFA-SECURITIES-INC
BOFA-SECURITIES-INC
70%
The Common Shares were sold pursuant to an Underwriting Agreement, dated December 2, 2025, between the Company and BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman S…
GOLDMAN-SACHS-CO-LLC
GOLDMAN-SACHS-CO-LLC
70%
The Common Shares were sold pursuant to an Underwriting Agreement, dated December 2, 2025, between the Company and BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman S…
J-P-MORGAN-SECURITIES-LLC
J-P-MORGAN-SECURITIES-LLC
70%
The Common Shares were sold pursuant to an Underwriting Agreement, dated December 2, 2025, between the Company and BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman S…
PIPER-SANDLER-CO
PIPER-SANDLER-CO
70%
The Common Shares were sold pursuant to an Underwriting Agreement, dated December 2, 2025, between the Company and BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman S…
Kestra Medical Technologies, Ltd. Customers
Ticker
Name
Confidence
Evidence
BIOBEAT-TECHNOLOGIES-LTD
BIOBEAT-TECHNOLOGIES-LTD
62%
l Transactions represent a business combination between entities under common control under the principles of ASC Topic 805, Business Combinations . In connection with the Organizational Transactions…
BOFA-SECURITIES-INC
BOFA-SECURITIES-INC
62%
perating losses and negative cash flows driven by substantial research and development expenses as well as our large investment in our fleet of ASSURE WCDs and building our commercial organization. O…
CO-J-P-MORGAN-SECURITIES-LLC
CO-J-P-MORGAN-SECURITIES-LLC
62%
perating losses and negative cash flows driven by substantial research and development expenses as well as our large investment in our fleet of ASSURE WCDs and building our commercial organization. O…
CO-LLC
CO-LLC
62%
perating losses and negative cash flows driven by substantial research and development expenses as well as our large investment in our fleet of ASSURE WCDs and building our commercial organization. O…
COMMON-SHARES-KESTRA-MEDICAL-TECHNOLOGIES-LTD
COMMON-SHARES-KESTRA-MEDICAL-TECHNOLOGIES-LTD
62%
e “Organizational Transactions”). Following the Organizational Transactions, pre-existing interests in Intermediate Holdings, as well as non-controlling interests of its subsidiaries, were exchanged …
INTERMEDIATE-HOLDINGS
INTERMEDIATE-HOLDINGS
62%
l Transactions represent a business combination between entities under common control under the principles of ASC Topic 805, Business Combinations . In connection with the Organizational Transactions…
KESTRA-MEDICAL-TECHNOLOGIES-INC
KESTRA-MEDICAL-TECHNOLOGIES-INC
62%
perating losses and negative cash flows driven by substantial research and development expenses as well as our large investment in our fleet of ASSURE WCDs and building our commercial organization. O…
PERCEPTIVE-CREDIT-HOLDINGS
PERCEPTIVE-CREDIT-HOLDINGS
62%
perating losses and negative cash flows driven by substantial research and development expenses as well as our large investment in our fleet of ASSURE WCDs and building our commercial organization. O…
WEST-AFFUM-HOLDINGS
WEST-AFFUM-HOLDINGS
62%
perating losses and negative cash flows driven by substantial research and development expenses as well as our large investment in our fleet of ASSURE WCDs and building our commercial organization. O…
Kestra Medical Technologies, Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
KMTS-DEBT-10538
Warrants outstanding: 2648000
90%
xbrl warrant detail from xbrl 2025-04-30.
KMTS-DEBT
Debt stack $42.6M
90%
Market cache reports total debt of $42.6M.
Kestra Medical Technologies, Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Kestra Medical Technologies, Ltd..
Kestra Medical Technologies, Ltd. Ownership
Holder
Name
Confidence
Evidence
KMTS-OWNER-BAIN-CAPITAL-INVESTORS-LLC
Bain Capital Investors LLC
90%
13F overlay lists Bain Capital Investors LLC as top holder; 104 tracked holders.
Kestra Medical Technologies, Ltd. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
Kestra Medical Technologies, Ltd. Supply Chain Intel
